GEODE CAPITAL MANAGEMENT, LLC - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 106 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is 12.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$531,284
+52.6%
655,906
+31.8%
0.00%
Q1 2023$348,266
+100554.9%
497,523
+1.4%
0.00%
Q4 2022$346
-100.0%
490,481
+5.9%
0.00%
Q3 2022$703,000
+121.1%
463,133
+44.3%
0.00%
Q2 2022$318,000
-62.2%
320,989
-45.1%
0.00%
Q1 2022$842,000
-71.3%
585,131
+4.0%
0.00%
Q4 2021$2,936,000
-6.8%
562,466
+4.1%
0.00%
Q3 2021$3,150,000
-31.1%
540,341
-4.8%
0.00%
-100.0%
Q2 2021$4,573,000
+3.9%
567,473
+7.3%
0.00%0.0%
Q1 2021$4,400,000
+24.2%
528,920
+13.1%
0.00%0.0%
Q4 2020$3,544,000
-28.1%
467,566
+1.1%
0.00%0.0%
Q3 2020$4,928,000
-30.8%
462,289
-1.6%
0.00%
-50.0%
Q2 2020$7,125,000
+91.9%
470,012
+5.5%
0.00%
+100.0%
Q1 2020$3,712,000
-71.3%
445,679
-41.7%
0.00%0.0%
Q4 2019$12,928,000
+84.7%
765,020
+102.9%
0.00%
-50.0%
Q3 2019$7,000,000
-14.9%
376,961
+4.8%
0.00%0.0%
Q2 2019$8,229,000
+18.0%
359,667
+8.5%
0.00%0.0%
Q1 2019$6,971,000
-1.5%
331,642
-46.1%
0.00%
+100.0%
Q4 2018$7,080,000
+3.3%
615,720
+106.2%
0.00%
-50.0%
Q3 2018$6,854,000
+7.8%
298,672
+4.8%
0.00%0.0%
Q2 2018$6,356,000
+5.9%
285,076
+8.5%
0.00%0.0%
Q1 2018$6,003,000
-8.0%
262,745
+5.5%
0.00%0.0%
Q4 2017$6,523,000
+17.7%
248,973
+0.8%
0.00%0.0%
Q3 2017$5,542,000
-16.1%
246,903
+2.2%
0.00%
-33.3%
Q2 2017$6,607,000
+20.6%
241,592
+6.7%
0.00%
+50.0%
Q1 2017$5,478,000
+21.4%
226,394
+4.1%
0.00%0.0%
Q4 2016$4,514,000
-21.8%
217,569
+2.7%
0.00%
-33.3%
Q3 2016$5,776,000
+102.0%
211,903
+6.6%
0.00%
+50.0%
Q2 2016$2,859,000
+6.2%
198,744
+6.1%
0.00%
+100.0%
Q1 2016$2,692,000
-29.4%
187,380
+5.6%
0.00%
-50.0%
Q4 2015$3,813,000
+46.1%
177,470
+10.0%
0.00%0.0%
Q3 2015$2,610,000
-36.6%
161,316
+1.2%
0.00%0.0%
Q2 2015$4,114,000
+15.1%
159,406
+0.3%
0.00%0.0%
Q1 2015$3,575,000
+18.6%
158,902
+1.2%
0.00%0.0%
Q4 2014$3,014,000
-10.9%
157,092
-0.3%
0.00%0.0%
Q3 2014$3,384,000
-7.5%
157,548
+11.9%
0.00%0.0%
Q2 2014$3,659,000
+35.6%
140,765
+13.7%
0.00%0.0%
Q1 2014$2,699,000
+107.0%
123,774
+15.8%
0.00%
+100.0%
Q4 2013$1,304,000
-8.1%
106,904
+1.0%
0.00%0.0%
Q3 2013$1,419,000
+159.4%
105,840
+57.2%
0.00%
Q2 2013$547,00067,3250.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 4,387,590$46,772,00015.62%
ORACLE INVESTMENT MANAGEMENT INC 4,091,749$43,618,0005.75%
GRIFFIN ASSET MANAGEMENT, INC. 1,439,613$15,346,0002.36%
Selkirk Management LLC 348,805$3,718,0001.18%
Chicago Capital, LLC 1,966,891$20,967,0001.08%
Trellus Management Company, LLC 46,834$499,0000.51%
Cannell & Co. 1,118,439$11,923,0000.44%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$1,652,0000.36%
Belpointe Asset Management LLC 419,406$3,982,0000.27%
TCI Wealth Advisors, Inc. 55,586$593,0000.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders